These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17686340)

  • 1. Cytotoxic immune responses mediated by monoclonal antibodies in MS: incorrectly dismissed as ineffective?
    Killestein J; Polman CH
    Int MS J; 2007 Jun; 14(2):39-40. PubMed ID: 17686340
    [No Abstract]   [Full Text] [Related]  

  • 2. Rationale for cytotoxic monoclonal antibodies in MS.
    Simpson BS; Coles AJ
    Int MS J; 2007 Jun; 14(2):48-56. PubMed ID: 17686343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technology evaluation: SGN-15, Seattle Genetics Inc.
    Smith S
    Curr Opin Mol Ther; 2001 Jun; 3(3):295-302. PubMed ID: 11497354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Getting specific: monoclonal antibodies in multiple sclerosis.
    Lutterotti A; Martin R
    Lancet Neurol; 2008 Jun; 7(6):538-47. PubMed ID: 18485317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating multiple sclerosis with natalizumab.
    Iaffaldano P; Lucchese G; Trojano M
    Expert Rev Neurother; 2011 Dec; 11(12):1683-92. PubMed ID: 22091593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and activities of the BR96-doxorubicin immunoconjugate.
    Hellström I; Hellström KE; Senter PD
    Methods Mol Biol; 2001; 166():3-16. PubMed ID: 11217374
    [No Abstract]   [Full Text] [Related]  

  • 7. Monoclonal antibodies used as prophylactic, therapeutic and diagnostic agents.
    Chakhtoura M; Abdelnoor AM
    Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):533-42. PubMed ID: 20196697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDX RA 4197X-RA, monoclonal antibody ricin A.
    Drugs R D; 2002; 3(2):111-2. PubMed ID: 12001810
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-conjugated monoclonal antibodies for the treatment of cancer.
    Lambert JM
    Curr Opin Pharmacol; 2005 Oct; 5(5):543-9. PubMed ID: 16087399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alemtuzumab in early multiple sclerosis].
    Killestein J; Polman CH
    Ned Tijdschr Geneeskd; 2009 Jan; 153(1-2):46. PubMed ID: 19198214
    [No Abstract]   [Full Text] [Related]  

  • 11. Natalizumab: targeting alpha4-integrins in multiple sclerosis.
    Engelhardt B; Kappos L
    Neurodegener Dis; 2008; 5(1):16-22. PubMed ID: 18075270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is natalizumab overshooting its rebound?
    Fox RJ; Kappos L
    Neurology; 2008 Mar; 70(13 Pt 2):1073-4. PubMed ID: 18362270
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple sclerosis and Natalizumab.
    Fiore D
    Am J Ther; 2007; 14(6):555-60. PubMed ID: 18090880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The trials and tribulations of Tysabri.
    Lancet Neurol; 2006 May; 5(5):373. PubMed ID: 16632299
    [No Abstract]   [Full Text] [Related]  

  • 15. Modern multiple sclerosis treatment - what is approved, what is on the horizon.
    Pilz G; Wipfler P; Ladurner G; Kraus J
    Drug Discov Today; 2008 Dec; 13(23-24):1013-25. PubMed ID: 18775508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging monoclonal antibody therapies for multiple sclerosis.
    Cree B
    Neurologist; 2006 Jul; 12(4):171-8. PubMed ID: 16832236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natalizumab: bound to rebound?
    Schiess N; Calabresi PA
    Neurology; 2009 Feb; 72(5):392-3. PubMed ID: 19188569
    [No Abstract]   [Full Text] [Related]  

  • 18. Does the flap of a butterfly's wings in Brazil set off a tornado in Texas?--The JC Virus Story in multiple sclerosis.
    Achiron A; Miron S; Shoenfeld Y
    Isr Med Assoc J; 2005 May; 7(5):283-5. PubMed ID: 15909458
    [No Abstract]   [Full Text] [Related]  

  • 19. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast track to MS drug.
    Sheridan C
    Nat Biotechnol; 2004 Aug; 22(8):939-41. PubMed ID: 15286635
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.